That's not too surprising. Not only would it be very risky for him to recommend ordering drugs from overseas, but on an MD's income, he can afford the domestic prices. LOL. Besides, he could surely cut a deal with a rep.Gloria wrote:When I told him I was considering getting Entocort from there, he said he wouldn't do it.
And I have a hunch that your fears about CIGNA and Advantage-Plus Meridian kicking Entocort into the tier 5 category somewhere down the line are well justified. Imagine what will happen if/when the word gets around, and they are flooded with new clients who select them solely on the basis of their Entocort prices. Eventually it will dawn on them that they are leaving way too much money on the table.
Tex